The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Michaloglou, Chrysiis ^a   Lehmann, Waltraut ^a,d   Martin, Typhaine ^a   Delaunay, Clara ^a   Hueber, Andreas ^a   Barys, Louise ^a   Niu, Honglin ^b   Billy, Eric ^a   Wartmann, Markus ^a   Ito, Moriko ^a   Wilson, Christopher J ^b   Digan, Mary Ellen ^b   Bauer, Andreas ^a   Voshol, Hans ^a   Christofori, Gerhard ^c   Sellers, William R ^b   Hofmann, Francesco ^a   Schmelzle, Tobias ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 14; REGULATOR PROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE ACTIVITY; GENE LOCATION; GENE TARGETING; MOLECULAR DYNAMICS; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; STABLE EXPRESSION; YES ASSOCIATED PROTEIN GENE;

CELL LINE; EPITHELIAL CELLS; HUMANS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84876184181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061916     Document Type: Article

References (41)

1. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
2. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
3. Zhao B, Lei QY, Guan KL, (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646.
4. Huang J, Wu S, Barrera J, Matthews K, Pan D, (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421-434.
5. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, et al. (2005) Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685.
6. Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, et al. (1999) Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 21: 177-181.
7. Wu S, Huang J, Dong J, Pan D, (2003) hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456.
8. Boggiano JC, Fehon RG, (2012) Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 22: 695-702.
9. Genevet A, Tapon N, (2011) The Hippo pathway and apico-basal cell polarity. Biochem J 436: 213-224.
10. Zhao B, Tumaneng K, Guan KL, (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13: 877-883.
11. Pan D, (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505.
12. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405-12410.
13. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. (2011) Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782-795.
14. Mauviel A, Nallet-Staub F, Varelas X, (2012) Integrating developmental signals: a Hippo in the (path)way. Oncogene 31: 1743-1756.
15. Varelas X, Wrana JL, (2012) Coordinating developmental signaling: novel roles for the Hippo pathway. Trends Cell Biol 22: 88-96.
16. Ito M, Barys L, O'Reilly T, Young S, Gorbatcheva B, et al. (2011) Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis. Clin Cancer Res 17: 416-426.
17. Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, et al. (2012) Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene 509: 215-222.
18. Wee S, Wiederschain D, Maira SM, Loo A, Miller C, et al. (2008) PTEN-deficient cancers depend on PIK3CB. Proc Natl Acad Sci U S A 105: 13057-13062.
19. Wiederschain D, Wee S, Chen L, Loo A, Yang G, et al. (2009) Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 8: 498-504.
20. Basu S, Totty NF, Irwin MS, Sudol M, Downward J, (2003) Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11: 11-23.
21. Levy D, Adamovich Y, Reuven N, Shaul Y, (2008) Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 29: 350-361.
22. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
23. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, et al. (2011) Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018-7026.
24. Oka T, Schmitt AP, Sudol M, (2012) Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene 31: 128-134.
25. Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D, (2011) Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 22: 3725-3733.
26. Wang W, Huang J, Chen J, (2011) Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286: 4364-4370.
27. Zhao B, Li L, Lu Q, Wang LH, Liu CY, et al. (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63.
28. Liu X, Yang N, Figel SA, Wilson KE, Morrison CD, et al. (2012) PTPN14 interacts with and negatively regulates the oncogenic function of YAP. Oncogene.
29. Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, et al. (2012) YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene.
30. Wang W, Huang J, Wang X, Yuan J, Li X, et al. (2012) PTPN14 is required for the density-dependent control of YAP1. Genes Dev 26: 1959-1971.
31. Wadham C, Gamble JR, Vadas MA, Khew-Goodall Y, (2003) The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. Mol Biol Cell 14: 2520-2529.
32. Jiang SW, Desai D, Khan S, Eberhardt NL, (2000) Cooperative binding of TEF-1 to repeated GGAATG-related consensus elements with restricted spatial separation and orientation. DNA Cell Biol 19: 507-514.
33. Miller E, Yang J, DeRan M, Wu C, Su AI, et al. (2012) Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol 19: 955-962.
34. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, et al. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150: 780-791.
35. Bork P, Sudol M, (1994) The WW domain: a signalling site in dystrophin? Trends Biochem Sci 19: 531-533.
36. Chen HI, Sudol M, (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A 92: 7819-7823.
37. Webb C, Upadhyay A, Giuntini F, Eggleston I, Furutani-Seiki M, et al. (2011) Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Biochemistry 50: 3300-3309.
38. Chen HI, Einbond A, Kwak SJ, Linn H, Koepf E, et al. (1997) Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J Biol Chem 272: 17070-17077.
39. Fotia AB, Ekberg J, Adams DJ, Cook DI, Poronnik P, et al. (2004) Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2. J Biol Chem 279: 28930-28935.
40. Poernbacher I, Baumgartner R, Marada SK, Edwards K, Stocker H, (2012) Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol 22: 389-396.
41. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, et al. (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304: 1164-1166.